{"title":"登革病毒血清4型感染不是通过快速抗原试验诊断,而是通过实时逆转录- pcr和酶联免疫吸附试验诊断:1例报告","authors":"Ryosaku Oshiro , Kayoko Hayakawa , Takahiro Maeki , Shigeru Tajima , Satoshi Taniguchi , Chang-Kweng Lim , Yutaro Akiyama , Kei Yamamoto , Shotaro Ide , Akitsugu Furumoto , Norio Ohmagari","doi":"10.1016/j.jiac.2025.102797","DOIUrl":null,"url":null,"abstract":"<div><div>A 39-year-old Japanese male visited our hospital with fever, headache, and joint pain after a 5-day trip to Malaysia. Blood tests revealed decreased white blood cell and platelet counts. Although dengue was suspected, a rapid diagnostic test (RDT) on the 5th day after symptom onset was negative for dengue virus (DENV) nonstructural protein 1 (NS1) antigen, DENV IgM antibody, and DENV IgG antibody. Since dengue could not be ruled out in light of the clinical symptoms, an additional real-time reverse transcription-PCR (RT-PCR) test and enzyme-linked immunosorbent assay (ELISA) were performed. The DENV serotype 4 (DENV-4) genome was detected in the serum using real-time RT-PCR. DENV NS1 antigen, IgM antibody, and IgG antibody were detected in the serum using ELISA. This is a case of dengue diagnosed based not on RDT but on real-time RT-PCR and ELISA. When RDT results are negative, but dengue is suspected, additional real-time RT-PCR or ELISA testing must be performed to correctly diagnose patients with DENV infection.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 10","pages":"Article 102797"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dengue virus serotype 4 infection diagnosed not by rapid antigen test, but by real-time reverse transcription-PCR and enzyme-linked immunosorbent assay: A case report\",\"authors\":\"Ryosaku Oshiro , Kayoko Hayakawa , Takahiro Maeki , Shigeru Tajima , Satoshi Taniguchi , Chang-Kweng Lim , Yutaro Akiyama , Kei Yamamoto , Shotaro Ide , Akitsugu Furumoto , Norio Ohmagari\",\"doi\":\"10.1016/j.jiac.2025.102797\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>A 39-year-old Japanese male visited our hospital with fever, headache, and joint pain after a 5-day trip to Malaysia. Blood tests revealed decreased white blood cell and platelet counts. Although dengue was suspected, a rapid diagnostic test (RDT) on the 5th day after symptom onset was negative for dengue virus (DENV) nonstructural protein 1 (NS1) antigen, DENV IgM antibody, and DENV IgG antibody. Since dengue could not be ruled out in light of the clinical symptoms, an additional real-time reverse transcription-PCR (RT-PCR) test and enzyme-linked immunosorbent assay (ELISA) were performed. The DENV serotype 4 (DENV-4) genome was detected in the serum using real-time RT-PCR. DENV NS1 antigen, IgM antibody, and IgG antibody were detected in the serum using ELISA. This is a case of dengue diagnosed based not on RDT but on real-time RT-PCR and ELISA. When RDT results are negative, but dengue is suspected, additional real-time RT-PCR or ELISA testing must be performed to correctly diagnose patients with DENV infection.</div></div>\",\"PeriodicalId\":16103,\"journal\":{\"name\":\"Journal of Infection and Chemotherapy\",\"volume\":\"31 10\",\"pages\":\"Article 102797\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1341321X25001941\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25001941","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Dengue virus serotype 4 infection diagnosed not by rapid antigen test, but by real-time reverse transcription-PCR and enzyme-linked immunosorbent assay: A case report
A 39-year-old Japanese male visited our hospital with fever, headache, and joint pain after a 5-day trip to Malaysia. Blood tests revealed decreased white blood cell and platelet counts. Although dengue was suspected, a rapid diagnostic test (RDT) on the 5th day after symptom onset was negative for dengue virus (DENV) nonstructural protein 1 (NS1) antigen, DENV IgM antibody, and DENV IgG antibody. Since dengue could not be ruled out in light of the clinical symptoms, an additional real-time reverse transcription-PCR (RT-PCR) test and enzyme-linked immunosorbent assay (ELISA) were performed. The DENV serotype 4 (DENV-4) genome was detected in the serum using real-time RT-PCR. DENV NS1 antigen, IgM antibody, and IgG antibody were detected in the serum using ELISA. This is a case of dengue diagnosed based not on RDT but on real-time RT-PCR and ELISA. When RDT results are negative, but dengue is suspected, additional real-time RT-PCR or ELISA testing must be performed to correctly diagnose patients with DENV infection.
期刊介绍:
The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.